Abivax (ABVX) Stock Price, Quote, News & History | Benzinga

SPY769.66+0.74%QQQ750.15+1.09%BTC/USD85,152.85+0.35%DIA510.53+0.38%GLD379.39−0.88%TLT77.61−0.13%

Abivax SA (ABVX) Stock Price, Quote, News & History

ABVXNASDAQ

Trade with Public

Trade with Public

$94.42

-0.68-0.72%

Last update: Oct 2, 12:38 PM

$95.66

0.560.59%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Compare Options Stock Report

Key Statistics

Open

$95.82

Close

-

Volume / Avg.

242.53K / 1.20M

Day Range

$93.50 - $95.82

52 Wk Range

69.81 - 148.83

Market Cap

$8.24B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

35

Short Interest

7.95%

Days to Cover

6.16

Recent Abivax SA News

These Analysts Slash Their Forecasts On Abivax Following H1 Results

Abivax missed EPS estimates but beat sales in H1; shares dipped. Wedbush and Truist cut price targets to $118 and $151.

Avi Kapoor

Nasdaq Gains Over 100 Points, Posts Weekly Gain: Investor Sentiment Improves Slightly, But Greed Index Remains in ‘Fear’ Zone

Market sentiment improved slightly but stayed in Fear; stocks were mixed, the Dow had its worst week since March.

Avi Kapoor

Accenture, Abivax and 3 Stocks to Watch Heading Into Monday

Stocks in focus: Abivax, Marygold and Neuphoria report losses; Accenture partners with Anthropic, while Lobo Technologies posts H1 growth.

Avi Kapoor

Abivax Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

Abivax will report H1 earnings Sept. 21; analysts expect a $1.08 loss/share and $1.86M revenue.

Avi Kapoor

This Amer Sports Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Analysts initiate: Buy—Abivax ($155), Amer Sports ($42) and more

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-197.02M

Investing Cash Flow (TTM)

-8.00M

Financing Cash Flow (TTM)

524.64M

Free Cash Flow (TTM)

-197.27M

Capital Expenditure (TTM)

-245.00K

Net Change in Cash (TTM)

329.31M

Analyst Trends and Forecast

0

0

0

0

May

7

2

Jun

2

Jul

4

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.85B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

19.98

Earnings Yield % (TTM)

-6.36%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$4.76

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

$155.00K

LT Debt Repayment (TTM)

-$47.15M

Total Cash

$387.99M

Debt to Equity

0.00

Issuance of Debt (TTM)

-$46.99M

Repayment of Debt (TTM)

-$47.15M